The study attempted to determine the underlying role and regulation mechanism of 3β‐hydroxysterol‐Δ24 reductase (DHCR24) in the pathophysiology of cerebral small vessel disease‐associated cognitive impairment (CSVD‐CI). Here, DHCR24 is linked to cerebral small vessel disease.